Company: HUM
Filing Date: 2025-03-28
Form Type: 424B5
Source: 0001628280-25-015313
Chunk: 8

Company: HUMANA INC
Filing Date: 2025-03-28
Form: 424B5
Chunk 8
---
 time and from time to time, at a redemption price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest to the redemption date.                                                                                                                   |
|:---------------------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Change of Control    |     | Upon a “Change of Control Triggering Event” (as defined under “Description of the Notes—Offer to Repurchase Upon Change of Control Triggering Event”), we will be required to make an offer to repurchase from holders of the notes all or a portion of their notes at the purchase price described in “Description of the Notes—Offer to Repurchase Upon Change of Control Triggering Event” in this prospectus supplement. |
| Covenants            |     | The indenture and the supplemental indenture governing the notes contain covenants that, subject to exceptions and qualifications:                                                                                                                                                                                                                                                                                           
 •limit our ability and the ability of our subsidiaries to create liens, and                                                                                                                                                                                                                                                                                                                                                  
 •limit our ability to consolidate, merge or transfer all or substantially all of our assets.                                                                                                                                                                                                                                                                                                                                 
 See “Description of the Notes—Covenants” in this prospectus supplement.                                                                                                                                                                                                                                                                                                                                                      |
| Use of Proceeds      |     | We estimate that our net proceeds from this offering, less underwriters’ discounts and our estimated costs of the offering, will be approximately $247 million. We intend to use the net proceeds from this offering for general corporate purposes, which may include the repayment of existing indebtedness. See “Use of Proceeds” in this prospectus supplement.                                                          |
| Additional Issuances |     | We may “re-open” the notes and issue an unlimited aggregate principal amount of additional notes in the future. See “Description of the Notes—Additional Issuances” in this prospectus supplement.                                                                                                                                                                                                                           |
| Risk Factors         |     | See “Risk Factors” beginning on pageS-4of this prospectus supplement and the other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus for a discussion of certain factors you should carefully consider before deciding to invest in the notes.                                                                                                                 |

<div align='center'>S-3</div>

Table of Content s

### RISK FACTORS
Before making a decision to invest in the notes, you should carefully consider the following:

• the risk factors described below and those contained in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus; and

• the other information